Director Leanne Kelly resigns from Windtree board; Andrew Kucharchuk appointed as replacement and Audit Committee chair

WINDTREE THERAPEUTICS INC /DE/

Leanne Kelly resigned from Windtree Therapeutics board effective July 29, 2025; she had been Audit Committee chair.
Andrew Kucharchuk appointed to board effective August 3, 2025, also appointed chair of Audit Committee.
Kucharchuk is CFO of Cero Therapeutics Holdings and Chain Bridge I; previously CFO of Theralink Technologies.
No material arrangements, transactions, or compensatory grants disclosed in connection with Kucharchuk's appointment.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.